4.8 Article

LUBAC-Recruited CYLD and A20 Regulate Gene Activation and Cell Death by Exerting Opposing Effects on Linear Ubiquitin in Signaling Complexes

Journal

CELL REPORTS
Volume 13, Issue 10, Pages 2258-2272

Publisher

CELL PRESS
DOI: 10.1016/j.celrep.2015.11.009

Keywords

-

Categories

Funding

  1. BRC [294880]
  2. Welton Foundation
  3. Cancer Research UK-UCL Centre
  4. Wellcome Trust [096831/Z/11/Z]
  5. BBSRC CASE studentship [BB/J013129/1]
  6. MRC
  7. Wellcome Trust [096831/Z/11/A] Funding Source: Wellcome Trust
  8. Biotechnology and Biological Sciences Research Council [1319955] Funding Source: researchfish
  9. Medical Research Council [MC_U117565398] Funding Source: researchfish
  10. The Francis Crick Institute [10142] Funding Source: researchfish
  11. Wellcome Trust [096831/Z/11/A] Funding Source: researchfish
  12. MRC [MC_U117565398] Funding Source: UKRI

Ask authors/readers for more resources

Ubiquitination and deubiquitination are crucial for assembly and disassembly of signaling complexes. LUBAC-generated linear (M1) ubiquitin is important for signaling via various immune receptors. We show here that the deubiquitinases CYLD and A20, but not OTULIN, are recruited to the TNFR1- and NOD2-associated signaling complexes (TNF-RSC and NOD2-SC), at which they cooperate to limit gene activation. Whereas CYLD recruitment depends on its interaction with LUBAC, but not on LUBAC's M1-chain-forming capacity, A20 recruitment requires this activity. Intriguingly, CYLD and A20 exert opposing effects on M1 chain stability in the TNF-RSC and NOD2-SC. While CYLD cleaves M1 chains, and thereby sensitizes cells to TNF-induced death, A20 binding to them prevents their removal and, consequently, inhibits cell death. Thus, CYLD and A20 cooperatively restrict gene activation and regulate cell death via their respective activities on M1 chains. Hence, the interplay between LUBAC, M1-ubiquitin, CYLD, and A20 is central for physiological signaling through innate immune receptors.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available